IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, is hosting an investor webinar, “Opportunities in the Emerging Markets,” on Monday, September 21 at 1:00 p.m. ET. The one-hour, interactive session will feature IMS’s Adel Al-Saleh, president, Europe, Middle East, and Africa; Ray Hill, general manager, Consulting and Services; and Mandy Chui, senior principal, Consulting. They will discuss the unique healthcare systems in the seven “pharmerging” markets, and how IMS is equipping clients to strengthen their market position through the company’s extensive information, analytics and consulting capabilities.
To listen to the live webinar and view accompanying slides, go to http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124&eventID=2443649.
To participate in the session via phone, use the following call-in numbers:
1 800 240-8929 (U.S. and Canada) | |||||
1 706 902-3004 (International) | |||||
Conference ID number to access call: 30809633 | |||||
A replay of the webcast will be available beginning at 4:00 p.m. ET on September 21 in the “Investors” area of IMS’s website at http://www.imshealth.com, and also by dialing:
1 800 642-1687 (U.S. and Canada) | |||||
1 706 645-9291 (International) | |||||
Conference ID number to access playback: 30809633 | |||||
About IMS
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.
Contacts:
IMS Health
Investor Relations:
Darcie Peck, 203-845-5237
dpeck@imshealth.com